Continuous Hyperfractionated Accelerated Radiotherapy (CHART) for Non-small Cell Lung Cancer (NSCLC): 7 Years' Experience From Nine UK Centres. - Sanganalmath, P.; Lester, J.E.; Bradshaw, A.G.; Das, T.; Esler, C.; Roy, A.E.F.; Toy, E.; Lester, J.F.; Button, M.; Wilson, P.; Comins, C.; Atherton, P.; et al. (Clinical Oncology, 2018)